Fenpyrazamine
- $1320
- Product name: Fenpyrazamine
- CAS: 473798-59-3
- MF: C17H21N3O2S
- MW: 331.43
- EINECS:
- MDL Number:
- Synonyms:1-[(2-Propenylthio)carbonyl]-2-(1-methylethyl)-4-(2-methylphenyl)-5-amino-1H-pyrazol-3-one;5-Amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-1H-pyrazole-1-carbothioic acid S-2-propen-1-yl ester;FenpyrazaMine;1H-Pyrazole-1-carbothioic acid, 5-amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-, S-2-propen-1-yl ester;Fenpyrazamine Standard;U9832;Fenpyrazamine (S-allyl 5-amino-2-isopropyl-4-(2-methylphenyl)-3-oxo-2,3-dihydropyrazole-1-carbothioate);S-Allyl 5-amino-2-isopropyl-3-oxo-4-(o-tolyl)-2,3-dihydro-1H-pyrazole-1-carbothioate
1 prices
Selected condition:
Brand
- TRC
Package
- 50mg
- ManufacturerTRC
- Product numberF249753
- Product descriptionFenpyrazamine
- Packaging50mg
- Price$1320
- Updated2021-12-16
- Buy
Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
---|---|---|---|---|---|---|
TRC | F249753 | Fenpyrazamine | 50mg | $1320 | 2021-12-16 | Buy |
Properties
Melting point :116.4℃
Boiling point :453.0±55.0 °C(Predicted)
Density :1.227
solubility :Chloroform (Sparingly), DMSO (Slightly)
pka :3.22±0.20(Predicted)
form :Solid
color :White to Off-White
Water Solubility :20.4 mg/L (20℃)
LogP :2.732 (est)
EPA Substance Registry System :1H-Pyrazole-1-carbothioic acid, 5-amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-, S-2-propen-1-yl ester (473798-59-3)
Boiling point :453.0±55.0 °C(Predicted)
Density :1.227
solubility :Chloroform (Sparingly), DMSO (Slightly)
pka :3.22±0.20(Predicted)
form :Solid
color :White to Off-White
Water Solubility :20.4 mg/L (20℃)
LogP :2.732 (est)
EPA Substance Registry System :1H-Pyrazole-1-carbothioic acid, 5-amino-2,3-dihydro-2-(1-methylethyl)-4-(2-methylphenyl)-3-oxo-, S-2-propen-1-yl ester (473798-59-3)
Safety Information
Symbol(GHS): | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Signal word: | Warning | ||||||||||||||
Hazard statements: |
|
||||||||||||||
Precautionary statements: |
|